Article
Drugs that Inhibit Tubulin Polymerization: The Particular Case of Podophyllotoxin and Analogues
25 Mar 2005
Abstract excerpt
Tubulin being a major cellular target for antitumor drugs, tubulin-interacting compounds have attracted great attention as antimitotic agents. Two main classes of antimitotic drugs are known and one of them includes podophyllotoxin, a natural product. The clinical use of podophyllotoxin in the treatment of cancer has been limited by severe toxic side effects. In an attempt to find less toxic analogues, many...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
